Detalles de la búsqueda
1.
Heart failure with mildly reduced and preserved ejection fraction: A review of disease burden and remaining unmet medical needs within a new treatment landscape.
Heart Fail Rev;
29(3): 631-662, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38411769
2.
High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database.
Nephrol Dial Transplant;
38(3): 630-643, 2023 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35389468
3.
Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors.
BMC Med;
20(1): 2, 2022 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35000594
4.
Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease.
J Nephrol;
36(4): 1135-1167, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36422853
5.
Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes.
J Med Econ;
26(1): 935-943, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439218
6.
Validation of the FINE-CKD model for future health technology assessments for finerenone in patients with chronic kidney disease and type 2 diabetes.
Am J Manag Care;
28(6 Suppl): S104-S111, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35997774
7.
ACE inhibitor or ARB treatment among patients with diabetes and chronic kidney disease.
Am J Manag Care;
27(20 Suppl): S360-S368, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34878753
8.
Cardiovascular and Renal Outcomes in Patients with Type-2 Diabetes and Chronic Kidney Disease Identified in a United States Administrative Claims Database: A Population Cohort Study.
Nephron;
145(4): 342-352, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33789294
9.
Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study.
Clin Kidney J;
14(6): 1657-1664, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34084461
10.
Targeted literature review of the burden of illness in patients with chronic kidney disease and type 2 diabetes.
Am J Manag Care;
27(8 Suppl): S168-S177, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34019359
11.
Adherence to Chronic Kidney Disease Screening Guidelines Among Patients With Type 2 Diabetes in a US Administrative Claims Database.
Mayo Clin Proc;
96(4): 975-986, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33722396
12.
FINE-CKD model to evaluate economic value of finerenone in patients with chronic kidney disease and type 2 diabetes.
Am J Manag Care;
27(20 Suppl): S375-S382, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34878755
13.
Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
J Manag Care Spec Pharm;
26(12): 1506-1516, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33251992
14.
Cost-effectiveness of rivaroxaban versus apixaban for the initial treatment of venous thromboembolism and extended prevention of recurrences in the UK.
J Med Econ;
22(11): 1179-1191, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31433687
15.
Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis.
Eur J Intern Med;
61: 29-33, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30342973
16.
Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review.
Expert Rev Pharmacoecon Outcomes Res;
19(1): 27-36, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30169975
17.
Thirteen-year trend in the persistence with vitamin K antagonists for venous thromboembolism in the UK: a cohort study.
Curr Med Res Opin;
34(11): 1985-1990, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29798688
18.
Patient-Reported Treatment Experience with Oral Rivaroxaban: Results from the Noninterventional XALIA Study of Deep-Vein Thrombosis.
TH Open;
2(2): e139-e146, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31249937
19.
The Burden of Major Adverse Cardiac Events and Antiplatelet Prevention in Patients with Coronary or Peripheral Arterial Disease.
Cardiovasc Ther;
34(2): 115-24, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26670723
20.
Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study.
Thromb Res;
206: 1-4, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34332213